Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Semler Scientific ( (SMLR) ) has provided an announcement.
On June 22, 2025, Semler Scientific‘s board of directors approved the Fifth Amended and Restated Bylaws, effective immediately. This amendment was made to clarify compliance with Delaware General Corporation Law and to align with the company’s certificate of incorporation, potentially impacting corporate governance and operational clarity.
The most recent analyst rating on (SMLR) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Semler Scientific stock, see the SMLR Stock Forecast page.
Spark’s Take on SMLR Stock
According to Spark, TipRanks’ AI Analyst, SMLR is a Neutral.
Semler Scientific faces significant financial challenges, with declining revenue and profitability, as well as a high leverage ratio. The technical analysis provides mixed signals, and the valuation metrics suggest caution due to negative earnings. While the earnings call and corporate events highlight ambitious growth plans and a successful bitcoin strategy, these are overshadowed by the immediate financial setbacks. The overall score reflects these mixed factors, emphasizing the need for the company to address its financial health and strategic execution.
To see Spark’s full report on SMLR stock, click here.
More about Semler Scientific
Semler Scientific operates in the healthcare industry, focusing on providing diagnostic and testing solutions to improve patient care and outcomes.
Average Trading Volume: 840,744
Technical Sentiment Signal: Sell
Current Market Cap: $403M
For a thorough assessment of SMLR stock, go to TipRanks’ Stock Analysis page.